HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kambayashi, T. Articles by Ljunggren, H.-G. Search for Related Content PubMed PubMed Citation Articles by Kambayashi, T. Articles by Ljunggren, H.-G. Pubmed/NCBI databases Substance via MeSH

Emergence of CD8⁺ T Cells Expressing NK Cell Receptors in Influenza A Virus-Infected Mice¹

Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden

	Abstract

Top Abstract Introduction Materials and Methods Results and Discussion References

 
Both innate and adaptive immune responses play an important role in the recovery of the host from viral infections. In the present report, a subset of cells coexpressing CD8 and NKR-P1C (NK1.1) was found in the lungs of mice infected with influenza A virus. These cells were detected at low numbers in the lungs of uninfected mice, but represented up to 10% of the total CD8⁺ T cell population at day 10 postinfection. Almost all of the CD8⁺NK1.1⁺ cells were CD8ß⁺CD3⁺TCRß⁺ and a proportion of these cells also expressed the NK cell-associated Ly49 receptors. Interestingly, up to 30% of these cells were virus-specific T cells as determined by MHC class I tetramer staining and by intracellular staining of IFN- after viral peptide stimulation. Moreover, these cells were distinct from conventional NKT cells as they were also found at increased numbers in influenza-infected CD1^-/- mice. These results demonstrate that a significant proportion of CD8⁺ T cells acquire NK1.1 and other NK cell-associated molecules, and suggests that these receptors may possibly regulate CD8⁺ T cell effector functions during viral infection.

	Introduction

Top Abstract Introduction Materials and Methods Results and Discussion References

 
Virus-specific CD8⁺ T cells are detected at high numbers in lungs of influenza virus-infected mice and play a critical role in viral clearance at late stages of infection (1). In many viral infections, innate immune cells such as NK cells are induced at earlier stages and are thought to control virus spread until the adaptive immune response is fully activated (2). NK cells can be activated by cytokines, such as type I IFNs and IL-12, and by viral glycoproteins (3, 4, 5). Several inhibitory and activating cell surface receptors including NKR-P1 and Ly49 regulate NK cell function (6). Ly49 receptors, which have specificity for MHC class I molecules, allow NK cells to discriminate between target cells expressing normal and low levels of MHC class I. In this respect, NK cells are able to complement CD8⁺ T cells in clearing infected cells expressing low levels of MHC class I molecules (6, 7). NKR-P1C (NK1.1) and some Ly49 molecules are also expressed on a distinct lymphocyte population known as NK T (3) cells (8, 9). Unlike normal T cells, most NKT cells display a largely invariant TCR repertoire and are restricted to the non-classical MHC class I molecule CD1 (9).

In the present report, a subset of T cells expressing both an innate (NK1.1, Ly49) and an adaptive (CD8/TCR) immune phenotype is described. These cells are clearly distinct from conventional NKT cells. The acquisition of NK cell-associated receptors by CD8⁺ T cells during viral infection suggests that these receptors may play an important role in regulating CD8⁺ T cell-mediated anti-viral immune responses.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results and Discussion References

 
Mice

C57BL/6 (B6) mice (8–12 wk old) were obtained from the Microbiology and Tumor Biology Center, Karolinska Institutet (Stockholm, Sweden). CD1^-/- mice were generated as described previously (10) and bred in-house at the Karolinska Institutet. Animal care was in accordance with institutional guidelines.

Cells and reagents

Madin Darby canine kidney (MDCK)³ cells (American Type Culture Collection, Manassas, VA) were grown in MEM containing Earle’s salts, 10 mM HEPES buffer, 5% FCS, and antibiotics (Life Technologies, Rockville, MD). All chemicals were purchased from Sigma (St. Louis, MO) unless otherwise specified. The influenza virus nucleoprotein-derived peptide (NP_366–374), ASNENMDAM, was purchased from Research Genetics (Huntsville, AL). All Abs used were purchased from PharMingen (Stockholm, Sweden). The murine ß₂-microglobulin sequence encoding amino acids 1–99 cloned into pET8c plasmid (cloned by P. Robinson, Birkbeck College, London, U.K.) was a kind gift from P. J. Travers (Birkbeck College, London, U.K.). The pET3c plasmid construct encoding the extracellular domain of the H-2D^b heavy chain modified with the substrate sequence for BirA biotinylation was a kind gift from T. N. M. Schumacher (The Netherlands Cancer Institute, Amsterdam, The Netherlands).

Preparation of cells from lungs of influenza-infected mice

Mice were infected intranasally with influenza virus A/Japan/305/57 in 50 ml of PBS at a dose of 1.5 x 10⁵ MDCK infectious units (30 PFU), corresponding to 1/10 LD₅₀. At specified days postinfection, both infected and control mice were sacrificed by cervical dislocation and their lungs were removed. The lungs were minced into small pieces and incubated in RPMI 1640 (10% FCS) with collagenase type IV (250 U/ml) for 90 min at 37°C. The erythrocytes were lysed, and single-cell suspensions were prepared from the digested organs. Finally, adherent cells were removed from the cellular suspensions by incubating the cells on tissue culture petri dishes for 90 min at 37°C, and the remaining cells were used for further analysis.

Construction of MHC class I tetramers

H-2D^b heavy chain and murine ß₂-microglobulin protein were produced in large quantities by purifying inclusion bodies from electrocompetent Escherichia coli, BL21(DE3)pLys bacteria transformed with the relevant plasmids as described elsewhere (11, 12). The protocol described by Garboczi et al. (13) was basically followed in refolding and purification of soluble MHC class I molecules. Briefly, 12 mg of H-2D^b heavy chain, 10 mg of murine ß₂-microglobulin, and 4 mg of NP_366–374 peptide were added to a 400-ml refolding solution. The solution was stirred slowly at 4°C for 72 h and concentrated to a volume of 2 ml by centrifugation filters with a cutoff of 10 kDa (Pall Gellman Laboratory, Lund, Sweden). The concentrate was placed on a fast protein liquid chromatography column (PharMingen), and the fraction peak corresponding to the refolded MHC class I molecule was collected and biotinylated using a commercial BirA biotinylation kit (Avidity, Denver, CO). Excess biotin was removed by a size exclusion column (NAP-5) with a 5-kDa cutoff (Amersham Pharmacia Biotech AB, Uppsala, Sweden) and eluted in PBS. The resulting biotinylated MHC monomer solution (D^b-NP366) was frozen to -80°C until further use. Before use, tetramers were generated by slowly adding streptavidin-PE or streptavidin-RED670 (Dakopatts AB, Sweden) to the MHC monomer solution at a 1:4 molar ratio.

Flow cytometry

Cells were Fc receptor blocked in 200 µl of tissue culture media containing anti-CD16/32 Ab for 30 min on ice. The cells were spun and resuspended in 50 µl of PBS containing the specified Ab (anti-CD3-Cy, -CD8-PE, -CD8ß-FITC, -NK1.1-PE, Ly49D-FITC) at a concentration of 0.5–2 µg/ml or D^b-NP366 (PE or RED670) tetramer (10 µg/ml). When staining with biotinylated Abs against Ly49A, C/I, G2, TCRß, and NK1.1, an extra staining with streptavidin RED670 (1:100) for 15 min was performed. An isotype control Ab conjugated with the respective fluorescent or biotinylation tag was used for negative control staining of each specific Ab. After 30 min on ice, the cells were washed with PBS and the fluorescence intensity was measured on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA). Finally, the data were analyzed using CellQuest computer software (Becton Dickinson).

Determination of influenza virus lung titers

Lungs from mice infected with influenza virus were harvested into 3 ml of ice-cold PBS, minced, and centrifuged at 400 x g for 3 min. Pellet fractions were homogenized in microcentrifuge tubes using disposable polypropylene pellet pestle mixers (Kebo Lab, Stockholm, Sweden). Each homogenate was pooled with its corresponding supernatant fraction and centrifuged at 20,000 x g for 1 min. Virus-containing supernatant aliquots were snap frozen in dry ice and stored at -80°C until assayed by immunofluorescence. For titrations, MDCK cells were incubated with MEM (0.2% BSA) containing serial dilutions of lung extracts for 1 h at 37°C. Complete MDCK medium was added and cells were incubated at 37°C. After 14 h, cells were washed with PBS, fixed with -20°C methanol, washed again, and incubated for 60 min first with PBS (0.2% BSA), then with the same buffer containing FITC-conjugated mouse anti-Influenza/A-NP (Virostat, Portland, OR), and finally washed with PBS. Infected cells were visualized using an UV microscope, scored, and virus titers were calculated as infectious (=fluorescent) units per lung.

Intracellular IFN- staining

Lung cells were stimulated with peptide and IL-2 (100 U/ml) for 6 h in the presence of Golgistop (PharMingen). The cells were washed twice and stained with FITC-conjugated anti-CD8ß and biotinylated/streptavidin RED670 anti-NK1.1 Ab. After fixation in cytofix/cytoperm solution (PharMingen), the cells were permeabilized and stained with either PE-conjugated anti-IFN- Ab or rat IgG1 isotype control Ab (PharMingen). The cells were analyzed on a flow cytometer using CellQuest computer software (Becton Dickinson).

	Results and Discussion

Top Abstract Introduction Materials and Methods Results and Discussion References

 
The number of cells coexpressing CD8ß and NK1.1 is significantly increased in the lungs of influenza A virus-infected mice

NK cells play a vital role in protection against many virus infections and are believed to be important during early phases of viral infection (14). To determine whether NK cells could play a role in late stages of viral infection, mice were infected with influenza A virus, and the presence of NK cells in the lungs was monitored between days 7 and 14 postinfection by flow cytometry. To our surprise, an increase in NK1.1⁺ cell numbers was observed in the lungs of influenza-infected mice between these time points. Double fluorescence analysis revealed that these cells were not classical NK cells, since they expressed CD8ß. As shown in Fig. 1A, the number of CD8ß⁺NK1.1⁺ cells was markedly higher compared with controls between days 7 and 14, reaching a maximum at day 10 postinfection. Along with relative percentages, absolute numbers of CD8ß⁺NK1.1⁺ cells were also significantly increased on day 10. There were 100,000 CD8ß⁺NK1.1⁺ cells/lung found on day 10 postinfection compared with 4,000 CD8ß⁺NK1.1⁺ cells/lung detected in uninfected controls (data not shown). Of note, careful precautions were taken when analyzing the T cells by flow cytometry. Each experiment was performed by blocking Fc receptors with anti-CD16/32 Ab, and the cells were gated so that <1% of CD8⁺ T cells stained positively for the respective isotype control Ab. Some experiments were also performed by blocking with normal mouse serum and similar results were obtained.

View larger version (16K): [in this window] [in a new window]   FIGURE 1. Detection of CD8ß+NK1.1+ cells and CD8ß+Db-NP366 tetramer+ cells in lungs of influenza virus-infected mice. Mice were injected intranasally with either influenza A virus or PBS. The lungs were removed at day 5, 7, 10, 14, and 18 postinfection and the lung cells were analyzed for expression of CD8ß/NK1.1 (A) or CD8ß/Db-NP366 tetramer (B) by flow cytometry. The results are expressed as mean percent positive cells of total CD8ß+ cells ± SD of three independent experiments (n = 3 or 4 mice per experiment). *, p < 0.05 compared with controls.

To relate these findings to adaptive immune responses that normally occur during this time frame (day 5–18), the presence of viral peptide-specific T cells was also monitored. To detect viral peptide-specific T cells in infected mice, H-2D^b MHC class I tetramers refolded with a D^b-binding influenza nucleoprotein peptide (D^b-NP366) were constructed (15, 16). CD8ß⁺D^b-NP366⁺ cells were detected abundantly in the lungs of influenza-infected mice (Fig. 1B). In absolute numbers, there were 300,000 CD8ß⁺D^b-NP366⁺ cells/lung found in influenza-infected mice on day 10 postinfection. Similar to CD8ß⁺NK1.1⁺ cells, the number of these cells peaked on day 10 postinfection. Distinct CD8ß⁺NK1.1⁺ and CD8ß⁺D^b-NP366⁺ populations of cells were observed on day 10 in influenza-infected mice (Fig. 2, B and D, upper right quadrant) compared with normal mice (Fig. 2, A and C, upper right quadrant).

View larger version (63K): [in this window] [in a new window]   FIGURE 2. Flow cytometric density analysis of CD8ß+NK1.1+ cells and CD8ß+Db-NP366 tetramer+ cells in lungs of influenza virus-infected mice on day 10 postinfection. Mice were injected intranasally with either influenza A virus or PBS. The lungs were removed at day 10 postinfection, and the lung cells were analyzed for expression of CD8ß/NK1.1 in untreated mice (A) or influenza-infected mice (B) and CD8ß/Db-NP366 tetramer in untreated mice (C) or influenza-infected mice (D) by flow cytometry. The number indicated in the upper right-hand corner represents the percentage of cells within the right upper quadrant of total CD8ß+ cells.

View larger version (13K): [in this window] [in a new window]   FIGURE 3. Virus lung titers in influenza virus-infected mice. At indicated time points after infection, lung virus titers were measured from influenza-infected mice as described in Materials and Methods. Values plotted below the dashed line indicate titers below the detection limit of the assay (3 x 102 IU (infectious units)/lung). Results are expressed as mean ± SD (n = 3 for days 5, 7, and 10 and n = 2 for days 13 and 18).

Lung cells prepared from influenza-infected and uninfected mice on day 10 were stained with Ab against CD8ß, NK1.1, and a T cell- or NK cell-associated molecule. The cells were gated into two subsets by flow cytometry, either CD8ß⁺/NK1.1^- or CD8ß⁺/NK1.1⁺, and analyzed for other T cell- and NK cell-associated markers. More than 97% of the CD8ß⁺NK1.1⁺ and CD8ß⁺NK1.1^- cells were CD8ß⁺TCRß⁺CD3⁺ (data not shown). A significantly higher proportion of the NK1.1⁺ cells expressed the NK cell inhibitory molecules Ly49A, C/I, and G2 and the NK cell-activating molecule Ly49D compared with the NK1.1^- cells (Table I). A representative FACS plot is shown in Fig. 4. Of note, the expression levels of Ly49 molecules were equal or only slightly less than those of conventional NK cells. These data suggest that CD8ß⁺NK1.1⁺ cells are potentially regulated by both T cell and NK cell-activating and inhibitory signals.

View larger version (21K): [in this window] [in a new window]   FIGURE 4. Expression of Ly49 receptors on CD8ß+NK1.1+ and CD8ß+NK1.1- cell subsets in lungs of influenza virus-infected mice on day 10 postinfection. The lungs of influenza-infected mice were removed at day 10 postinfection, and the lung cells were triple stained with Ab against CD8ß, NK1.1, and an Ab against the Ly49 receptor indicated at the top of each histogram plot. The cells were gated into two subsets, CD8ß+NK1.1+ or CD8ß+NK1.1, and the binding of isotype control Ab or Ab against Ly49 receptors was analyzed. The number indicated in the histogram plot represents the percentage of positive cells within that region.

To see whether CD8ß⁺NK1.1⁺ cells were virus specific, lung cells were triple stained with CD8ß, NK1.1, and D^b-NP366 tetramer. Interestingly, we found that a higher proportion of the CD8ß⁺NK1.1⁺ cells stained positive for the D^b-NP366 tetramer than the CD8ß⁺ NK1.1^- cells (Table II and Fig. 5A). Although the tetramer staining showed that the viral peptide MHC class I complex bound to the TCR of these cells, it was important to demonstrate that the TCR was functional. There was also a possibility that the tetramers bound to Ly49 receptors expressed on the CD8ß⁺NK1.1⁺ cells. To demonstrate that the CD8ß⁺NK1.1⁺ cells could respond to the viral peptide, intracellular staining of IFN- was performed on cells obtained from the lung. When stimulated with the viral peptide, there were two times more IFN--producing cells in the CD8ß⁺NK1.1⁺ subset compared with the CD8ß⁺NK1.1^- subset (Table II and Fig. 5B). Taken together, these results strongly suggest that a large proportion of these CD8ß⁺NK1.1⁺ cells were activated virus-specific T cells. In addition, we examined the proportion of CD8ß⁺D^b-NP366⁺ cells that expressed NK1.1. A higher proportion of CD8ß⁺D^b-NP366⁺ cells were NK1.1⁺ than CD8ß⁺ cells that were D^b-NP366 tetramer negative (Fig. 6).

View larger version (24K): [in this window] [in a new window]   FIGURE 5. Db-NP366 tetramer binding and intracellular IFN- staining of CD8ß+NK1.1+ and CD8ß+NK1.1- cell subsets in lungs of influenza virus-infected mice on day 10 postinfection. A, The lungs of influenza-infected mice were removed at day 10 postinfection and the lung cells were triple stained with Ab against CD8ß, NK1.1, and Db-NP366 tetramer. The cells were gated into two subsets, CD8ß+NK1.1+ or CD8ß+NK1.1, and the binding of Db-NP366 tetramer was analyzed. B, Lungs cells were stimulated with ASNENMDAM peptide (1 µM) and IL-2 (100 U/ml) for 6 h and the cells were triple stained with Ab against CD8ß, NK1.1 and isotype control Ab or anti-IFN- Ab. The cells were gated into two subsets, CD8ß+NK1.1+ or CD8ß+NK1.1, and intracellular IFN- was analyzed. The number indicated in the histogram plot represents the percentage of positive cells within that region.

View larger version (27K): [in this window] [in a new window]   FIGURE 6. Expression of NK1.1 on CD8ß+Db-NP366 tetramer+ and CD8ß+Db-NP366 tetramer- cell subsets in lungs of influenza virus-infected mice on day 10 postinfection. The lungs of influenza-infected mice were removed at day 10 postinfection and the lung cells were triple stained with Ab against CD8ß, NK1.1, and Db-NP366 tetramer. The cells were gated into two subsets, CD8ß+ Db-NP366 tetramer+ or CD8ß+ Db-NP366 tetramer-, and the binding of isotype control Ab or anti-NK1.1 Ab was analyzed. The number indicated in the histogram plot represents the percentage of positive cells within that region.

Conventional NKT cells which possess both TCR and NK cell-associated markers have previously been described (9). Several lines of evidence indicate that the CD8ß⁺NK1.1⁺ cells in our study were different from conventional NKT cells. First, conventional NKT cells have been documented to be CD4^-CD8^- or CD4⁺CD8^- (8, 9). Second, CD8ß⁺NK1.1⁺ cells were detected in the lungs of influenza-infected CD1^-/- mice which lack NKT cells (Fig. 7). Third, conventional NKT cells are restricted to CD1, whereas the CD8ß⁺NK1.1⁺ cells stained positively for H-2D^b tetramers, suggesting their restriction to H-2D^b and not to CD1.

View larger version (31K): [in this window] [in a new window]   FIGURE 7. Flow cytometric density analysis of CD8ß+NK1.1+ cells in lungs of influenza virus-infected CD1-/- mice on day 10 postinfection. CD1-/- mice were injected intranasally with either influenza A virus or PBS. The lungs were removed at day 10 postinfection and the lung cells were analyzed for expression of CD8ß/NK1.1 in untreated mice (A) or influenza-infected mice (B) by flow cytometry. The number indicated in the upper right-hand corner represents the percentage of cells within the right upper quadrant of total CD8ß+ cells.

As mentioned earlier, cytokines such as IL-2, IL-4, and IL-15 were able to induce NK1.1 and Ly49 expression on CD8⁺ T cells in vitro. The acquisition of these receptors was found to be dependent on CD122 (IL-2Rß) (18). In line with this observation, we found that a majority of the CD8ß⁺NK1.1⁺ and CD8ß⁺D^b-NP366⁺ cells were also CD122⁺ (data not shown). Since most of the tetramer-positive T cells expressed CD122, it was not surprising to find that a significant proportion of the CD8ß⁺NK1.1⁺ cells was virus specific. Thus, the emergence of CD8ß⁺NK1.1⁺ T cells in vivo may also be mediated by cytokines such as IL-2.

The presence of CD8⁺ T cells expressing NK cell-associated markers has been observed in other models. In mice, treatment with IL-2 and IL-4 induced a population of cells that was CD8⁺TCRß⁺NK1.1⁺ in B cell-depleted (20) and NK cell-depleted splenocytes (21). In a virus model, spleens of lymphocytic choriomeningitis virus-infected mice contained CD8⁺ T cells that expressed NK1.1 (22). In the bone marrow of mice, expression of NK1.1 and Ly49 molecules have been shown to be associated with memory T cells (23). Studies performed in humans have described activated CD8⁺ T cells that possess NKR-P1C (24) or inhibitory NK cell receptors such as p58.2 (25, 26, 27), NKB-1 (27, 28), and CD94/NKG2A (25, 29, 30). Similar T cells have also been found in HIV-infected patients (31). Many of these studies propose that the presence of NK cell inhibitory molecules on T cells could either be a disadvantage to the host by inhibiting T cells that are necessary for the recovery of the host from disease or an advantage in cases of autoimmunity or graft-versus- host disease. Likewise in our system, the up-regulation of inhibitory Ly49 receptors on CD8⁺ T cells may potentially serve to dampen the immune response, e.g., by suppressing overactivated T cells that may be a potential hazard to the host. In addition, expression of Ly49 inhibitory receptors on nonspecific T cells may suppress bystander activation. In support of this notion, a previous study performed in Ly49A transgenic mice demonstrated that the expression of Ly49A inhibitory receptors on T cells can modulate activated T cell responses (32).

Concluding remarks

In conclusion, we demonstrate the emergence of NK cell-like CD8⁺ T cells in the lungs of influenza virus-infected B6 mice. These CD8⁺ T cells express activating and inhibitory cell surface receptors characteristic of NK cells. A large proportion of these cells bound MHC class I tetramers refolded with a viral nucleoprotein epitope and produced IFN- in response to peptide restimulation, suggesting that many of these cells were activated virus-specific CTL. The demonstration of NK cell-associated molecules on T cells reveal novel regulatory mechanisms in controlling the effector functions of T cells.

	Acknowledgments

 
We thank Dr. T. N. M. Schumacher for providing us with the H-2D^b heavy chain construct and Dr. P. J. Travers for the murine ß₂-microglobulin construct. We also thank members of the H. G. Ljunggren laboratory for fruitful discussions.

	Footnotes

 
¹ This work was supported by the Foundation of Strategic Research, the Karolinska Institutet, the Swedish Medical Research Council, the Swedish Cancer Society, the Barncancerfonden, the Tobias Foundation, the Åke Wiberg Foundation, the Alex and Eva Wallström Foundation, and the Lars Hiertas Foundation.

² Address correspondence and reprint requests to Dr. Hans-Gustaf Ljunggren, Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, S-171 77, Sweden.

³ Abbreviations used in this paper: MDCK, Madin Darby canine kidney; NP, nucleoprotein-derived peptide.

Received for publication March 29, 2000. Accepted for publication August 8, 2000.

	References

Top Abstract Introduction Materials and Methods Results and Discussion References

 

1. Eichelberger, M., W. Allan, M. Zijlstra, R. Jaenisch, P. C. Doherty. 1991. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8⁺ T cells. J. Exp. Med. 174:875.[Abstract/Free Full Text]
2. Biron, C. A.. 1997. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:24.[Medline]
3. Welsh, R. M.. 1984. Natural killer cells and interferon. Crit. Rev. Immunol. 5:55.[Medline]
4. Trinchieri, G.. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.[Medline]
5. Arora, D. J., M. Houde, D. M. Justewicz, R. Mandeville. 1984. In vitro enhancement of human natural cell-mediated cytotoxicity by purified influenza virus glycoproteins. J. Virol. 52:839.[Abstract/Free Full Text]
6. Lanier, L. L.. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359.[Medline]
7. Ljunggren, H. G., K. Kärre. 1990. In search of the ’missing self’: MHC molecules and NK cell recognition. Immunol. Today 11:237.[Medline]
8. Vicari, A. P., A. Zlotnik. 1996. Mouse NK1.1⁺ T cells: a new family of T cells. Immunol. Today 17:71.[Medline]
9. Bendelac, A., M. N. Rivera, S. H. Park, J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.[Medline]
10. Mendiratta, S. K., W. D. Martin, S. Hong, A. Boesteanu, S. Joyce, L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6:469.[Medline]
11. Haanen, J. B., M. Toebes, T. A. Cordaro, M. C. Wolkers, A. M. Kruisbeek, T. N. Schumacher. 1999. Systemic T cell expansion during localized viral infection. Eur. J. Immunol. 29:1168.[Medline]
12. Achour, A., R. A. Harris, K. Persson, J. Sundback, C. L. Sentman, G. Schneider, Y. Lindqvist, K. Kärre. 1999. Murine class I major histocompatibility complex H-2D^d: expression, refolding and crystallization. Acta Crystallogr. D 55:260.[Medline]
13. Garboczi, D. N., D. T. Hung, D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89:3429.[Abstract/Free Full Text]
14. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189.[Medline]
15. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.[Abstract/Free Full Text]
16. Flynn, K. J., G. T. Belz, J. D. Altman, R. Ahmed, D. L. Woodland, P. C. Doherty. 1998. Virus-specific CD8⁺ T cells in primary and secondary influenza pneumonia. Immunity 8:683.[Medline]
17. Koo, G. C., F. J. Dumont, M. Tutt, Jr J. Hackett, V. Kumar. 1986. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J. Immunol. 137:3742.[Abstract]
18. Assarsson, E., T. Kambayashi, J. K. Sandberg, S. Hong, M. Taniguchi, L. van Kaer, H. G. Ljunggren, and B. J. Chambers. 2000. CD8⁺ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J. Immunol. In press.
19. Asea, A., J. Stein-Streilein. 1998. Signalling through NK1.1 triggers NK cells to die but induces NK T cells to produce interleukin-4. Immunology 93:296.[Medline]
20. Ballas, Z. K., W. Rasmussen. 1993. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1⁺CD8 ⁺ß^- TCR-ß B220⁺ lymphokine-activated killer subset. J. Immunol. 150:17.[Abstract]
21. Ikarashi, Y., H. Maruoka, K. Shinohara, T. Sugimura, M. Terada, H. Wakasugi. 1998. Mouse NK1.1⁺ cytotoxic T cells can be generated by IL-2 exposure from lymphocytes which express an intermediate level of T cell receptor. Immunol. Lett. 61:165.[Medline]
22. Slifka, M. K., R. R. Pagarigan, J. L. Whitton. 2000. NK markers are expressed on a high percentage of virus-specific CD8⁺ and CD4⁺ T cells. J. Immunol. 164:2009.[Abstract/Free Full Text]
23. Coles, M. C., C. W. McMahon, H. Takizawa, D. H. Raulet. 2000. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur. J. Immunol. 30:236.[Medline]
24. Ishihara, S., M. Nieda, J. Kitayama, T. Osada, T. Yabe, Y. Ishikawa, H. Nagawa, T. Muto, T. Juji. 1999. CD8⁺NKR-P1A⁺T cells preferentially accumulate in human liver. Eur. J. Immunol. 29:2406.[Medline]
25. Mingari, M. C., C. Vitale, A. Cambiaggi, F. Schiavetti, G. Melioli, S. Ferrini, A. Poggi. 1995. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 7:697.[Abstract/Free Full Text]
26. Mingari, M. C., F. Schiavetti, M. Ponte, C. Vitale, E. Maggi, S. Romagnani, J. Demarest, G. Pantaleo, A. S. Fauci, L. Moretta. 1996. Human CD8⁺ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 93:12433.[Abstract/Free Full Text]
27. Phillips, J. H., J. E. Gumperz, P. Parham, L. L. Lanier. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403.[Abstract/Free Full Text]
28. D’Andrea, A., C. Chang, J. H. Phillips, L. L. Lanier. 1996. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J. Exp. Med. 184:789.[Abstract/Free Full Text]
29. Mingari, M. C., M. Ponte, S. Bertone, F. Schiavetti, C. Vitale, R. Bellomo, A. Moretta, L. Moretta. 1998. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8⁺ T cells. Proc. Natl. Acad. Sci. USA 95:1172.[Abstract/Free Full Text]
30. Speiser, D. E., M. J. Pittet, D. Valmori, R. Dunbar, D. Rimoldi, D. Lienard, H. R. MacDonald, J. C. Cerottini, V. Cerundolo, P. Romero. 1999. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med. 190:775.[Abstract/Free Full Text]
31. De Maria, A., A. Ferraris, M. Guastella, S. Pilia, C. Cantoni, L. Polero, M. C. Mingari, D. Bassetti, A. S. Fauci, L. Moretta. 1997. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl. Acad. Sci. USA 94:10285.[Abstract/Free Full Text]
32. Zajac, A. J., R. E. Vance, W. Held, D. J. Sourdive, J. D. Altman, D. H. Raulet, R. Ahmed. 1999. Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J. Immunol. 163:5526.[Abstract/Free Full Text]

This article has been cited by other articles:

				G. Alter, S. Rihn, H. Streeck, N. Teigen, A. Piechocka-Trocha, K. Moss, K. Cohen, A. Meier, F. Pereyra, B. Walker, et al. Ligand-Independent Exhaustion of Killer Immunoglobulin-Like Receptor-Positive CD8+ T Cells in Human Immunodeficiency Virus Type 1 Infection J. Virol., October 1, 2008; 82(19): 9668 - 9677. [Abstract] [Full Text] [PDF]

				N. K. Bjorkstrom, V. D. Gonzalez, K.-J. Malmberg, K. Falconer, A. Alaeus, G. Nowak, C. Jorns, B.-G. Ericzon, O. Weiland, J. K. Sandberg, et al. Elevated Numbers of Fc{gamma}RIIIA+ (CD16+) Effector CD8 T Cells with NK Cell-Like Function in Chronic Hepatitis C Virus Infection J. Immunol., September 15, 2008; 181(6): 4219 - 4228. [Abstract] [Full Text] [PDF]

				J Nattermann, G Feldmann, G Ahlenstiel, B Langhans, T Sauerbruch, and U Spengler Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C Gut, June 1, 2006; 55(6): 869 - 877. [Abstract] [Full Text] [PDF]

				D. Atanackovic, K. Pollok, C. Faltz, I. Boeters, R. Jung, A. Nierhaus, K.-M. Braumann, D. K. Hossfeld, and S. Hegewisch-Becker Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R585 - R594. [Abstract] [Full Text] [PDF]

				S. S. Smith, T. Patterson, and M. E. Pauza Transgenic Ly-49A Inhibits Antigen-Driven T Cell Activation and Delays Diabetes J. Immunol., April 1, 2005; 174(7): 3897 - 3905. [Abstract] [Full Text] [PDF]

				M. Giroux and F. Denis CD1d-unrestricted human NKT cells release chemokines upon Fas engagement Blood, January 15, 2005; 105(2): 703 - 710. [Abstract] [Full Text] [PDF]

				M. Guma, A. Angulo, C. Vilches, N. Gomez-Lozano, N. Malats, and M. Lopez-Botet Imprint of human cytomegalovirus infection on the NK cell receptor repertoire Blood, December 1, 2004; 104(12): 3664 - 3671. [Abstract] [Full Text] [PDF]

				N. Anfossi, S. H. Robbins, S. Ugolini, P. Georgel, K. Hoebe, C. Bouneaud, C. Ronet, A. Kaser, C. B. DiCioccio, E. Tomasello, et al. Expansion and Function of CD8+ T Cells Expressing Ly49 Inhibitory Receptors Specific for MHC Class I Molecules J. Immunol., September 15, 2004; 173(6): 3773 - 3782. [Abstract] [Full Text] [PDF]

				J. E. Gumperz CD1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses? J. Leukoc. Biol., August 1, 2004; 76(2): 307 - 313. [Abstract] [Full Text] [PDF]

				K. Adachi, H. Tsutsui, E. Seki, H. Nakano, K. Takeda, K. Okumura, L. Van Kaer, and K. Nakanishi Contribution of CD1d-unrestricted hepatic DX5+ NKT cells to liver injury in Plasmodium berghei-parasitized erythrocyte-injected mice Int. Immunol., June 1, 2004; 16(6): 787 - 798. [Abstract] [Full Text] [PDF]

				M. Maeda, A. Shadeo, A. M. MacFadyen, and F. Takei CD1d-Independent NKT Cells in {beta}2-Microglobulin-Deficient Mice Have Hybrid Phenotype and Function of NK and T Cells J. Immunol., May 15, 2004; 172(10): 6115 - 6122. [Abstract] [Full Text] [PDF]

				D. Yuan, R. Bibi, and T. Dang The role of adjuvant on the regulatory effects of NK cells on B cell responses as revealed by a new model of NK cell deficiency Int. Immunol., May 1, 2004; 16(5): 707 - 716. [Abstract] [Full Text] [PDF]

				D. Atanackovic, A. Block, A. de Weerth, C. Faltz, D. K. Hossfeld, and S. Hegewisch-Becker Characterization of Effusion-Infiltrating T Cells: Benign versus Malignant Effusions Clin. Cancer Res., April 15, 2004; 10(8): 2600 - 2608. [Abstract] [Full Text] [PDF]

				L. Saurer, I. Seibold, C. Vallan, W. Held, and C. Mueller Cutting Edge: Stimulation with the Cognate Self-Antigen Induces Expression of the Ly49A Receptor on Self-Reactive T Cells Which Modulates Their Responsiveness J. Immunol., December 15, 2003; 171(12): 6334 - 6338. [Abstract] [Full Text] [PDF]

				K. U. Saikh, B. Dyas, T. Kissner, and R. G. Ulrich CD56+-T-Cell Responses to Bacterial Superantigens and Immune Recognition of Attenuated Vaccines Clin. Vaccine Immunol., November 1, 2003; 10(6): 1065 - 1073. [Abstract] [Full Text] [PDF]

				P. Lundberg, P. Welander, H. Openshaw, C. Nalbandian, C. Edwards, L. Moldawer, and E. Cantin A Locus on Mouse Chromosome 6 That Determines Resistance to Herpes Simplex Virus Also Influences Reactivation, While an Unlinked Locus Augments Resistance of Female Mice J. Virol., November 1, 2003; 77(21): 11661 - 11673. [Abstract] [Full Text] [PDF]

				C. N. Baxevanis, A. D. Gritzapis, and M. Papamichail In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18 J. Immunol., September 15, 2003; 171(6): 2953 - 2959. [Abstract] [Full Text] [PDF]

				M. Saito, V. M. Braud, P. Goon, E. Hanon, G. P. Taylor, A. Saito, N. Eiraku, Y. Tanaka, K. Usuku, J. N. Weber, et al. Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers Blood, July 15, 2003; 102(2): 577 - 584. [Abstract] [Full Text] [PDF]

				S. H. Robbins, S. C. Terrizzi, B. C. Sydora, T. Mikayama, and L. Brossay Differential Regulation of Killer Cell Lectin-Like Receptor G1 Expression on T Cells J. Immunol., June 15, 2003; 170(12): 5876 - 5885. [Abstract] [Full Text] [PDF]

				X. Gu, A. Laouar, J. Wan, M. Daheshia, J. Lieberman, W. M. Yokoyama, H. R. Katz, and N. Manjunath The gp49B1 Inhibitory Receptor Regulates the IFN-{gamma} Responses of T Cells and NK Cells J. Immunol., April 15, 2003; 170(8): 4095 - 4101. [Abstract] [Full Text] [PDF]

				D. Zipris, J.-L. Hillebrands, R. M. Welsh, J. Rozing, J. X. Xie, J. P. Mordes, D. L. Greiner, and A. A. Rossini Infections That Induce Autoimmune Diabetes in BBDR Rats Modulate CD4+CD25+ T Cell Populations J. Immunol., April 1, 2003; 170(7): 3592 - 3602. [Abstract] [Full Text] [PDF]

				A. B. Geldhof, J. A. Van Ginderachter, Y. Liu, W. Noel, G. Raes, and P. De Baetselier Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation Blood, December 1, 2002; 100(12): 4049 - 4058. [Abstract] [Full Text] [PDF]

				K. B. Gurney, O. O. Yang, S. B. Wilson, and C. H. Uittenbogaart TCR{gamma}{delta}+ and CD161+ Thymocytes Express HIV-1 in the SCID-hu Mouse, Potentially Contributing to Immune Dysfunction in HIV Infection J. Immunol., November 1, 2002; 169(9): 5338 - 5346. [Abstract] [Full Text] [PDF]

				Y. Mizukawa, Y. Yamazaki, Y. Teraki, J. Hayakawa, K. Hayakawa, H. Nuriya, M. Kohara, and T. Shiohara Direct Evidence for Interferon-{gamma} Production by Effector-Memory-Type Intraepidermal T Cells Residing at an Effector Site of Immunopathology in Fixed Drug Eruption Am. J. Pathol., October 1, 2002; 161(4): 1337 - 1347. [Abstract] [Full Text] [PDF]

				C. W. McMahon, A. J. Zajac, A. M. Jamieson, L. Corral, G. E. Hammer, R. Ahmed, and D. H. Raulet Viral and Bacterial Infections Induce Expression of Multiple NK Cell Receptors in Responding CD8+ T Cells J. Immunol., August 1, 2002; 169(3): 1444 - 1452. [Abstract] [Full Text] [PDF]

				J. D. Miller, M. Peters, A. E. Oran, G. W. Beresford, L. Harrington, J. M. Boss, and J. D. Altman CD94/NKG2 Expression Does Not Inhibit Cytotoxic Function of Lymphocytic Choriomeningitis Virus-Specific CD8+ T Cells J. Immunol., July 15, 2002; 169(2): 693 - 701. [Abstract] [Full Text] [PDF]

				N. Ohta, T. Hiroi, M.-N. Kweon, N. Kinoshita, M. H. Jang, T. Mashimo, J.-I. Miyazaki, and H. Kiyono IL-15-Dependent Activation-Induced Cell Death-Resistant Th1 Type CD8{alpha}{beta}+NK1.1+ T Cells for the Development of Small Intestinal Inflammation J. Immunol., July 1, 2002; 169(1): 460 - 468. [Abstract] [Full Text] [PDF]

				S. Korten, L. Volkmann, M. Saeftel, K. Fischer, M. Taniguchi, B. Fleischer, and A. Hoerauf Expansion of NK Cells with Reduction of Their Inhibitory Ly-49A, Ly-49C, and Ly-49G2 Receptor-Expressing Subsets in a Murine Helminth Infection: Contribution to Parasite Control J. Immunol., May 15, 2002; 168(10): 5199 - 5206. [Abstract] [Full Text] [PDF]

				J. E. Gumperz, S. Miyake, T. Yamamura, and M. B. Brenner Functionally Distinct Subsets of CD1d-restricted Natural Killer T Cells Revealed by CD1d Tetramer Staining J. Exp. Med., March 4, 2002; 195(5): 625 - 636. [Abstract] [Full Text] [PDF]

				T. Kambayashi, E. Assarsson, B. J. Chambers, and H.-G. Ljunggren Cutting Edge: Regulation of CD8+ T Cell Proliferation by 2B4/CD48 Interactions J. Immunol., December 15, 2001; 167(12): 6706 - 6710. [Abstract] [Full Text] [PDF]

				K. J. L. Hammond, D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey CD1d-Restricted NKT Cells: An Interstrain Comparison J. Immunol., August 1, 2001; 167(3): 1164 - 1173. [Abstract] [Full Text] [PDF]

				K. A. Daniels, G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh Murine Cytomegalovirus Is Regulated by a Discrete Subset of Natural Killer Cells Reactive with Monoclonal Antibody to Ly49H J. Exp. Med., June 25, 2001; 194(1): 29 - 44. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kambayashi, T. Articles by Ljunggren, H.-G. Search for Related Content PubMed PubMed Citation Articles by Kambayashi, T. Articles by Ljunggren, H.-G. Pubmed/NCBI databases Substance via MeSH